Qualigen Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference
Rhea-AI Summary
Qualigen Therapeutics (Nasdaq: QLGN) will be presenting at the H.C. Wainwright BioConnect 2021 Virtual Conference from January 11-14, 2021. The presentation will be delivered by Michael Poirier, the Chairman and CEO of the company. Investors can access the presentation via webcast on-demand, starting January 11, 2021, on the Qualigen Therapeutics website, specifically in the Investors section.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, QLGN gained 3.81%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
CARLSBAD, Calif., Jan. 5, 2021 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, today announced that Michael Poirier, Chairman, Chief Executive Officer and President, will present at the H.C. Wainwright BioConnect 2021 Virtual Conference to be held January 11-14, 2021.
A webcast of the presentation will be accessible on demand beginning Monday, January 11, 2021 on the Qualigen Therapeutics website, https://www.qualigeninc.com/, in the Investors section.
View original content:http://www.prnewswire.com/news-releases/qualigen-therapeutics-to-present-at-the-hc-wainwright-bioconnect-2021-conference-301200916.html
SOURCE Qualigen, Inc.
FAQ
When is Qualigen presenting at the H.C. Wainwright BioConnect 2021 Virtual Conference?
Who will present on behalf of Qualigen at the conference?
How can I access the Qualigen presentation?
What is the stock symbol for Qualigen Therapeutics?
Where can I find more information about Qualigen Therapeutics?
